日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

ZNFX1 在癌症中作为表观遗传诱导的病原体模拟和炎症小体信号传导的主调节因子发挥作用

Stojanovic Lora, Abbotts Rachel, Tripathi Kaushelendra, Coon Collin M, Rajendran Saranya, Abbasi Farid Elnaz, Hostetter Galen, Guarnieri Joseph W, Wallace Douglas C, Liu Sheng, Wan Jun, Calendo Gennaro, Marker Rebecca, Gohari Zahra, Inayatullah Mohammed M A, Tiwari Vijay K, Kader Tanjina, Santagata Sandro, Drapkin Ronny, Kommoss Stefan, Pfisterer Jacobus, Konecny Gottfried E, Coopergard Ryan, Issa Jean-Pierre J, Winterhoff Boris J N, Topper Michael J, Sandusky George E, Miller Kathy D, Baylin Stephen B, Nephew Kenneth P, Rassool Feyruz V

Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes

致命的 COVID-19 与 RAAS 诱导的炎症有关,可导致包括纵隔淋巴结在内的多器官损伤。

Topper, Michael J; Guarnieri, Joseph W; Haltom, Jeffrey A; Chadburn, Amy; Cope, Henry; Frere, Justin; An, Julia; Borczuk, Alain; Sinha, Saloni; Kim, JangKeun; Park, Jiwoon; Butler, Daniel; Meydan, Cem; Foox, Jonathan; Bram, Yaron; Richard, Stephanie A; Epsi, Nusrat J; Agan, Brian; Chenoweth, Josh G; Simons, Mark P; Tribble, David; Burgess, Timothy; Dalgard, Clifton; Heise, Mark T; Moorman, Nathaniel J; Baxter, Victoria K; Madden, Emily A; Taft-Benz, Sharon A; Anderson, Elizabeth J; Sanders, Wes A; Dickmander, Rebekah J; Beigel, Katherine; Widjaja, Gabrielle A; Janssen, Kevin A; Lie, Timothy; Murdock, Deborah G; Angelin, Alessia; Soto Albrecht, Yentli E; Olali, Arnold Z; Cen, Zimu; Dybas, Joseph; Priebe, Waldemar; Emmett, Mark R; Best, Sonja M; Kelsey Johnson, Maya; Trovao, Nidia S; Clark, Kevin B; Zaksas, Victoria; Meller, Robert; Grabham, Peter; Schisler, Jonathan C; Moraes-Vieira, Pedro M; Pollett, Simon; Mason, Christopher E; Syrkin Wurtele, Eve; Taylor, Deanne; Schwartz, Robert E; Beheshti, Afshin; Wallace, Douglas C; Baylin, Stephen B

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

一项针对接受初始免疫检查点抑制剂治疗后进展的转移性尿路上皮癌患者的Guadecitabine联合Atezolizumab II期临床试验

Jang, H Josh; Hostetter, Galen; Macfarlane, Alexander W; Madaj, Zachary; Ross, Eric A; Hinoue, Toshinori; Kulchycki, Justin R; Burgos, Ryan S; Tafseer, Mahvish; Alpaugh, R Katherine; Schwebel, Candice L; Kokate, Rutika; Geynisman, Daniel M; Zibelman, Matthew R; Ghatalia, Pooja; Nichols, Peter W; Chung, Woonbok; Madzo, Jozef; Hahn, Noah M; Quinn, David I; Issa, Jean-Pierre J; Topper, Michael J; Baylin, Stephen B; Shen, Hui; Campbell, Kerry S; Jones, Peter A; Plimack, Elizabeth R

The emerging role of epigenetic therapeutics in immuno-oncology

表观遗传疗法在肿瘤免疫学中的新兴作用

Topper, Michael J; Vaz, Michelle; Marrone, Kristen A; Brahmer, Julie R; Baylin, Stephen B